DEFINITIVE PROXY

Company

NRX Pharmaceuticals, Inc.

Filed

December 7, 2020

Period of Report

December 18, 2020

Accession Number

0001654954-20-013249

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →